Protective Effects of Increasing Vitamin E and A Doses on Cisplatin-Induced Oxidative Damage to Kidney Tissue in Rats

Objective: Cisplatin (DDP, cis-diamminedichloroplatinium II) is one of the most potent chemotherapeutic antitumor drugs, but is able to generate reactive oxygen species (ROS) and it also inhibits the activity of antioxidant enzymes in renal tissue. In the present study, we investigated the preventiv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urologia internationalis 2005-01, Vol.75 (4), p.340-344
Hauptverfasser: Dillioglugil, Meltem Ozlen, Maral Kir, Hale, Gulkac, Mehmet Dogan, Özon Kanli, Aylin, Ozdogan, Hacı Kahya, Acar, Oguz, Dillioglugil, Ozdal
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 344
container_issue 4
container_start_page 340
container_title Urologia internationalis
container_volume 75
creator Dillioglugil, Meltem Ozlen
Maral Kir, Hale
Gulkac, Mehmet Dogan
Özon Kanli, Aylin
Ozdogan, Hacı Kahya
Acar, Oguz
Dillioglugil, Ozdal
description Objective: Cisplatin (DDP, cis-diamminedichloroplatinium II) is one of the most potent chemotherapeutic antitumor drugs, but is able to generate reactive oxygen species (ROS) and it also inhibits the activity of antioxidant enzymes in renal tissue. In the present study, we investigated the preventive effect of 100, 200 and 400 mg/kg b.w. doses of vitamin E (VE), and 25, 50, and 100 mg/kg b.w. doses of vitamin A (VA) combination on malondialdehyde (MDA), nitric oxide (NO), and glutathione (GSH) levels and superoxide dismutase (SOD) activity in cisplatin-induced toxicity in rat kidneys. Our literature survey indicated a lack of any experimental study showing the beneficial effect of VA on cisplatin-induced MDA, NO, GSH and SOD changes. For this reason, we hoped that this study would provide a unique contribution in that respect. Materials and Methods: 59 Wistar rats (11 to replace prematurely lost animals) were used. 48 evaluable rats were divided into 8 groups (n = 6 in each group): control group, DDP alone (5 mg/kg b.w.) group, 3 VE combination treatment groups of VE100+DDP, VE200+DDP, and VE400+DDP, and 3 VA combination treatment groups of VA25+DDP, VA50+DDP, and VA100+DDP. Kidney MDA, GSH, NO levels and SOD activities were determined for the assessment of oxidant-antioxidant balance. Results: While in the DDP group the tissue levels of MDA and NO were found to be significantly higher than in the control group, GSH levels and SOD activities were significantly lower. MDA and NO levels were found to be significantly lower and GSH levels and SOD activities significantly higher in the VE200+DDP and VE400+ DDP groups when compared with the DDP alone group. MDA and NO levels were found to be significantly lower in the VA50+DDP and VA100+DDP groups when compared with the DDP alone group. However, identical comparisons with the DDP alone group showed significantly higher GSH levels and SOD activities in the VA25+DDP, VA50+DDP, and VA100+DDP groups. Among the VE100+ DDP, VE200+DDP, and VE400+DDP groups, and VA25+ DDP, VA50+DDP, and VA100+DDP groups, MDA and NO levels decreased and GSH levels and SOD activities increased steadily and significantly as the doses of VE and VA increased. Conclusion: These vitamins would be effective in protecting against cisplatin-induced tissue damage in rat kidneys. It is possible that the toxic effect of cisplatin is somehow minimized by a compensatory mechanism involving VE and VA via induction of antioxidant enzyme activities foll
doi_str_mv 10.1159/000089171
format Article
fullrecord <record><control><sourceid>pubmed_karge</sourceid><recordid>TN_cdi_karger_primary_89171</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16327303</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-1f6fb78313dd7f5401a8096b020a10c9f9d4e0395c1297fcb3910b86efb44bb93</originalsourceid><addsrcrecordid>eNpF0M1LwzAYBvAgipvTg2dBcvVQzdt0bXMc29ThYCLTa8nniK7pSFpx_73RyszlzeGXhzcPQpdAbgHG7I7EUzIo4AgNIUtpQihjx2hISJYmALQcoLMQ3gmJmBWnaAA5TQtK6BB1z75ptWztp8ZzY-It4MbghZNe82DdBr_ZltfW4TnmTuEJnjVBR-Pw1IbdlrfWJQunOqkVXn1ZxX-jZrzmG43bBj9Z5fQer20IncYx54W34RydGL4N-uJvjtDr_Xw9fUyWq4fFdLJMZFyuTcDkRhQlBapUYcYZAV4SlguSEg5EMsNUpuNfxxJSVhgpKAMiylwbkWVCMDpCN32u9E0IXptq523N_b4CUv1UVx2qi_a6t7tO1Fr9y7-uIrjqwQf3G-0PoH_-DQC9cVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Protective Effects of Increasing Vitamin E and A Doses on Cisplatin-Induced Oxidative Damage to Kidney Tissue in Rats</title><source>Karger Journals</source><source>MEDLINE</source><creator>Dillioglugil, Meltem Ozlen ; Maral Kir, Hale ; Gulkac, Mehmet Dogan ; Özon Kanli, Aylin ; Ozdogan, Hacı Kahya ; Acar, Oguz ; Dillioglugil, Ozdal</creator><creatorcontrib>Dillioglugil, Meltem Ozlen ; Maral Kir, Hale ; Gulkac, Mehmet Dogan ; Özon Kanli, Aylin ; Ozdogan, Hacı Kahya ; Acar, Oguz ; Dillioglugil, Ozdal</creatorcontrib><description>Objective: Cisplatin (DDP, cis-diamminedichloroplatinium II) is one of the most potent chemotherapeutic antitumor drugs, but is able to generate reactive oxygen species (ROS) and it also inhibits the activity of antioxidant enzymes in renal tissue. In the present study, we investigated the preventive effect of 100, 200 and 400 mg/kg b.w. doses of vitamin E (VE), and 25, 50, and 100 mg/kg b.w. doses of vitamin A (VA) combination on malondialdehyde (MDA), nitric oxide (NO), and glutathione (GSH) levels and superoxide dismutase (SOD) activity in cisplatin-induced toxicity in rat kidneys. Our literature survey indicated a lack of any experimental study showing the beneficial effect of VA on cisplatin-induced MDA, NO, GSH and SOD changes. For this reason, we hoped that this study would provide a unique contribution in that respect. Materials and Methods: 59 Wistar rats (11 to replace prematurely lost animals) were used. 48 evaluable rats were divided into 8 groups (n = 6 in each group): control group, DDP alone (5 mg/kg b.w.) group, 3 VE combination treatment groups of VE100+DDP, VE200+DDP, and VE400+DDP, and 3 VA combination treatment groups of VA25+DDP, VA50+DDP, and VA100+DDP. Kidney MDA, GSH, NO levels and SOD activities were determined for the assessment of oxidant-antioxidant balance. Results: While in the DDP group the tissue levels of MDA and NO were found to be significantly higher than in the control group, GSH levels and SOD activities were significantly lower. MDA and NO levels were found to be significantly lower and GSH levels and SOD activities significantly higher in the VE200+DDP and VE400+ DDP groups when compared with the DDP alone group. MDA and NO levels were found to be significantly lower in the VA50+DDP and VA100+DDP groups when compared with the DDP alone group. However, identical comparisons with the DDP alone group showed significantly higher GSH levels and SOD activities in the VA25+DDP, VA50+DDP, and VA100+DDP groups. Among the VE100+ DDP, VE200+DDP, and VE400+DDP groups, and VA25+ DDP, VA50+DDP, and VA100+DDP groups, MDA and NO levels decreased and GSH levels and SOD activities increased steadily and significantly as the doses of VE and VA increased. Conclusion: These vitamins would be effective in protecting against cisplatin-induced tissue damage in rat kidneys. It is possible that the toxic effect of cisplatin is somehow minimized by a compensatory mechanism involving VE and VA via induction of antioxidant enzyme activities following intraperitoneal injection of DDP.</description><identifier>ISSN: 0042-1138</identifier><identifier>EISSN: 1423-0399</identifier><identifier>DOI: 10.1159/000089171</identifier><identifier>PMID: 16327303</identifier><language>eng</language><publisher>Basel, Switzerland</publisher><subject>Animals ; Antineoplastic Agents - toxicity ; Antioxidants - administration &amp; dosage ; Biomarkers - metabolism ; Cisplatin - toxicity ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Female ; Glutathione - metabolism ; Kidney - drug effects ; Kidney - metabolism ; Kidney - pathology ; Kidney Diseases - chemically induced ; Kidney Diseases - metabolism ; Kidney Diseases - prevention &amp; control ; Lipid Peroxidation - drug effects ; Male ; Malondialdehyde - metabolism ; Nitric Oxide - metabolism ; Original Paper ; Oxidative Stress - drug effects ; Rats ; Rats, Wistar ; Superoxide Dismutase - metabolism ; Treatment Outcome ; Vitamin D - administration &amp; dosage ; Vitamin E - administration &amp; dosage ; Vitamins - administration &amp; dosage</subject><ispartof>Urologia internationalis, 2005-01, Vol.75 (4), p.340-344</ispartof><rights>2005 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c303t-1f6fb78313dd7f5401a8096b020a10c9f9d4e0395c1297fcb3910b86efb44bb93</citedby><cites>FETCH-LOGICAL-c303t-1f6fb78313dd7f5401a8096b020a10c9f9d4e0395c1297fcb3910b86efb44bb93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,2423,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16327303$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dillioglugil, Meltem Ozlen</creatorcontrib><creatorcontrib>Maral Kir, Hale</creatorcontrib><creatorcontrib>Gulkac, Mehmet Dogan</creatorcontrib><creatorcontrib>Özon Kanli, Aylin</creatorcontrib><creatorcontrib>Ozdogan, Hacı Kahya</creatorcontrib><creatorcontrib>Acar, Oguz</creatorcontrib><creatorcontrib>Dillioglugil, Ozdal</creatorcontrib><title>Protective Effects of Increasing Vitamin E and A Doses on Cisplatin-Induced Oxidative Damage to Kidney Tissue in Rats</title><title>Urologia internationalis</title><addtitle>Urol Int</addtitle><description>Objective: Cisplatin (DDP, cis-diamminedichloroplatinium II) is one of the most potent chemotherapeutic antitumor drugs, but is able to generate reactive oxygen species (ROS) and it also inhibits the activity of antioxidant enzymes in renal tissue. In the present study, we investigated the preventive effect of 100, 200 and 400 mg/kg b.w. doses of vitamin E (VE), and 25, 50, and 100 mg/kg b.w. doses of vitamin A (VA) combination on malondialdehyde (MDA), nitric oxide (NO), and glutathione (GSH) levels and superoxide dismutase (SOD) activity in cisplatin-induced toxicity in rat kidneys. Our literature survey indicated a lack of any experimental study showing the beneficial effect of VA on cisplatin-induced MDA, NO, GSH and SOD changes. For this reason, we hoped that this study would provide a unique contribution in that respect. Materials and Methods: 59 Wistar rats (11 to replace prematurely lost animals) were used. 48 evaluable rats were divided into 8 groups (n = 6 in each group): control group, DDP alone (5 mg/kg b.w.) group, 3 VE combination treatment groups of VE100+DDP, VE200+DDP, and VE400+DDP, and 3 VA combination treatment groups of VA25+DDP, VA50+DDP, and VA100+DDP. Kidney MDA, GSH, NO levels and SOD activities were determined for the assessment of oxidant-antioxidant balance. Results: While in the DDP group the tissue levels of MDA and NO were found to be significantly higher than in the control group, GSH levels and SOD activities were significantly lower. MDA and NO levels were found to be significantly lower and GSH levels and SOD activities significantly higher in the VE200+DDP and VE400+ DDP groups when compared with the DDP alone group. MDA and NO levels were found to be significantly lower in the VA50+DDP and VA100+DDP groups when compared with the DDP alone group. However, identical comparisons with the DDP alone group showed significantly higher GSH levels and SOD activities in the VA25+DDP, VA50+DDP, and VA100+DDP groups. Among the VE100+ DDP, VE200+DDP, and VE400+DDP groups, and VA25+ DDP, VA50+DDP, and VA100+DDP groups, MDA and NO levels decreased and GSH levels and SOD activities increased steadily and significantly as the doses of VE and VA increased. Conclusion: These vitamins would be effective in protecting against cisplatin-induced tissue damage in rat kidneys. It is possible that the toxic effect of cisplatin is somehow minimized by a compensatory mechanism involving VE and VA via induction of antioxidant enzyme activities following intraperitoneal injection of DDP.</description><subject>Animals</subject><subject>Antineoplastic Agents - toxicity</subject><subject>Antioxidants - administration &amp; dosage</subject><subject>Biomarkers - metabolism</subject><subject>Cisplatin - toxicity</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Glutathione - metabolism</subject><subject>Kidney - drug effects</subject><subject>Kidney - metabolism</subject><subject>Kidney - pathology</subject><subject>Kidney Diseases - chemically induced</subject><subject>Kidney Diseases - metabolism</subject><subject>Kidney Diseases - prevention &amp; control</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Male</subject><subject>Malondialdehyde - metabolism</subject><subject>Nitric Oxide - metabolism</subject><subject>Original Paper</subject><subject>Oxidative Stress - drug effects</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Treatment Outcome</subject><subject>Vitamin D - administration &amp; dosage</subject><subject>Vitamin E - administration &amp; dosage</subject><subject>Vitamins - administration &amp; dosage</subject><issn>0042-1138</issn><issn>1423-0399</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0M1LwzAYBvAgipvTg2dBcvVQzdt0bXMc29ThYCLTa8nniK7pSFpx_73RyszlzeGXhzcPQpdAbgHG7I7EUzIo4AgNIUtpQihjx2hISJYmALQcoLMQ3gmJmBWnaAA5TQtK6BB1z75ptWztp8ZzY-It4MbghZNe82DdBr_ZltfW4TnmTuEJnjVBR-Pw1IbdlrfWJQunOqkVXn1ZxX-jZrzmG43bBj9Z5fQer20IncYx54W34RydGL4N-uJvjtDr_Xw9fUyWq4fFdLJMZFyuTcDkRhQlBapUYcYZAV4SlguSEg5EMsNUpuNfxxJSVhgpKAMiylwbkWVCMDpCN32u9E0IXptq523N_b4CUv1UVx2qi_a6t7tO1Fr9y7-uIrjqwQf3G-0PoH_-DQC9cVg</recordid><startdate>20050101</startdate><enddate>20050101</enddate><creator>Dillioglugil, Meltem Ozlen</creator><creator>Maral Kir, Hale</creator><creator>Gulkac, Mehmet Dogan</creator><creator>Özon Kanli, Aylin</creator><creator>Ozdogan, Hacı Kahya</creator><creator>Acar, Oguz</creator><creator>Dillioglugil, Ozdal</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20050101</creationdate><title>Protective Effects of Increasing Vitamin E and A Doses on Cisplatin-Induced Oxidative Damage to Kidney Tissue in Rats</title><author>Dillioglugil, Meltem Ozlen ; Maral Kir, Hale ; Gulkac, Mehmet Dogan ; Özon Kanli, Aylin ; Ozdogan, Hacı Kahya ; Acar, Oguz ; Dillioglugil, Ozdal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-1f6fb78313dd7f5401a8096b020a10c9f9d4e0395c1297fcb3910b86efb44bb93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - toxicity</topic><topic>Antioxidants - administration &amp; dosage</topic><topic>Biomarkers - metabolism</topic><topic>Cisplatin - toxicity</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Glutathione - metabolism</topic><topic>Kidney - drug effects</topic><topic>Kidney - metabolism</topic><topic>Kidney - pathology</topic><topic>Kidney Diseases - chemically induced</topic><topic>Kidney Diseases - metabolism</topic><topic>Kidney Diseases - prevention &amp; control</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Male</topic><topic>Malondialdehyde - metabolism</topic><topic>Nitric Oxide - metabolism</topic><topic>Original Paper</topic><topic>Oxidative Stress - drug effects</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Treatment Outcome</topic><topic>Vitamin D - administration &amp; dosage</topic><topic>Vitamin E - administration &amp; dosage</topic><topic>Vitamins - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dillioglugil, Meltem Ozlen</creatorcontrib><creatorcontrib>Maral Kir, Hale</creatorcontrib><creatorcontrib>Gulkac, Mehmet Dogan</creatorcontrib><creatorcontrib>Özon Kanli, Aylin</creatorcontrib><creatorcontrib>Ozdogan, Hacı Kahya</creatorcontrib><creatorcontrib>Acar, Oguz</creatorcontrib><creatorcontrib>Dillioglugil, Ozdal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Urologia internationalis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dillioglugil, Meltem Ozlen</au><au>Maral Kir, Hale</au><au>Gulkac, Mehmet Dogan</au><au>Özon Kanli, Aylin</au><au>Ozdogan, Hacı Kahya</au><au>Acar, Oguz</au><au>Dillioglugil, Ozdal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protective Effects of Increasing Vitamin E and A Doses on Cisplatin-Induced Oxidative Damage to Kidney Tissue in Rats</atitle><jtitle>Urologia internationalis</jtitle><addtitle>Urol Int</addtitle><date>2005-01-01</date><risdate>2005</risdate><volume>75</volume><issue>4</issue><spage>340</spage><epage>344</epage><pages>340-344</pages><issn>0042-1138</issn><eissn>1423-0399</eissn><abstract>Objective: Cisplatin (DDP, cis-diamminedichloroplatinium II) is one of the most potent chemotherapeutic antitumor drugs, but is able to generate reactive oxygen species (ROS) and it also inhibits the activity of antioxidant enzymes in renal tissue. In the present study, we investigated the preventive effect of 100, 200 and 400 mg/kg b.w. doses of vitamin E (VE), and 25, 50, and 100 mg/kg b.w. doses of vitamin A (VA) combination on malondialdehyde (MDA), nitric oxide (NO), and glutathione (GSH) levels and superoxide dismutase (SOD) activity in cisplatin-induced toxicity in rat kidneys. Our literature survey indicated a lack of any experimental study showing the beneficial effect of VA on cisplatin-induced MDA, NO, GSH and SOD changes. For this reason, we hoped that this study would provide a unique contribution in that respect. Materials and Methods: 59 Wistar rats (11 to replace prematurely lost animals) were used. 48 evaluable rats were divided into 8 groups (n = 6 in each group): control group, DDP alone (5 mg/kg b.w.) group, 3 VE combination treatment groups of VE100+DDP, VE200+DDP, and VE400+DDP, and 3 VA combination treatment groups of VA25+DDP, VA50+DDP, and VA100+DDP. Kidney MDA, GSH, NO levels and SOD activities were determined for the assessment of oxidant-antioxidant balance. Results: While in the DDP group the tissue levels of MDA and NO were found to be significantly higher than in the control group, GSH levels and SOD activities were significantly lower. MDA and NO levels were found to be significantly lower and GSH levels and SOD activities significantly higher in the VE200+DDP and VE400+ DDP groups when compared with the DDP alone group. MDA and NO levels were found to be significantly lower in the VA50+DDP and VA100+DDP groups when compared with the DDP alone group. However, identical comparisons with the DDP alone group showed significantly higher GSH levels and SOD activities in the VA25+DDP, VA50+DDP, and VA100+DDP groups. Among the VE100+ DDP, VE200+DDP, and VE400+DDP groups, and VA25+ DDP, VA50+DDP, and VA100+DDP groups, MDA and NO levels decreased and GSH levels and SOD activities increased steadily and significantly as the doses of VE and VA increased. Conclusion: These vitamins would be effective in protecting against cisplatin-induced tissue damage in rat kidneys. It is possible that the toxic effect of cisplatin is somehow minimized by a compensatory mechanism involving VE and VA via induction of antioxidant enzyme activities following intraperitoneal injection of DDP.</abstract><cop>Basel, Switzerland</cop><pmid>16327303</pmid><doi>10.1159/000089171</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0042-1138
ispartof Urologia internationalis, 2005-01, Vol.75 (4), p.340-344
issn 0042-1138
1423-0399
language eng
recordid cdi_karger_primary_89171
source Karger Journals; MEDLINE
subjects Animals
Antineoplastic Agents - toxicity
Antioxidants - administration & dosage
Biomarkers - metabolism
Cisplatin - toxicity
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Glutathione - metabolism
Kidney - drug effects
Kidney - metabolism
Kidney - pathology
Kidney Diseases - chemically induced
Kidney Diseases - metabolism
Kidney Diseases - prevention & control
Lipid Peroxidation - drug effects
Male
Malondialdehyde - metabolism
Nitric Oxide - metabolism
Original Paper
Oxidative Stress - drug effects
Rats
Rats, Wistar
Superoxide Dismutase - metabolism
Treatment Outcome
Vitamin D - administration & dosage
Vitamin E - administration & dosage
Vitamins - administration & dosage
title Protective Effects of Increasing Vitamin E and A Doses on Cisplatin-Induced Oxidative Damage to Kidney Tissue in Rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A37%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protective%20Effects%20of%20Increasing%20Vitamin%20E%20and%20A%20Doses%20on%20Cisplatin-Induced%20Oxidative%20Damage%20to%20Kidney%20Tissue%20in%20Rats&rft.jtitle=Urologia%20internationalis&rft.au=Dillioglugil,%20Meltem%20Ozlen&rft.date=2005-01-01&rft.volume=75&rft.issue=4&rft.spage=340&rft.epage=344&rft.pages=340-344&rft.issn=0042-1138&rft.eissn=1423-0399&rft_id=info:doi/10.1159/000089171&rft_dat=%3Cpubmed_karge%3E16327303%3C/pubmed_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16327303&rfr_iscdi=true